ExCulture
PrivateLast Round
Seed
Jul 12, 2024
Total Funding Raised
$461,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ExCulture is a biotechnology company that develops a novel mixed-culture fermentation bioprocess to produce an animal-free substitute for heparin.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExCulture Comparables
Compare ExCulture with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Optimvia | 84% | |
| Cellweaverse | 78% | |
| Glycan Therapeutics | 75% |
ExCulture Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 12, 2024 | ||||
| Grant | Apr 12, 2024 | ||||
| Seed | Dec 10, 2023 | ||||
| Grant | Jun 30, 2023 |
ExCulture Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capricorn Partners | Seed |
| Libertatis Ergo Holding | Seed |
| Netherlands Organization for Scientific Research | Grant |
| Life Sciences @ Work Venture Challenge | Grant |
| Innovation Industries | Seed |
| Delft Enterprises | Seed |
| InnovationQuarter | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 288% MoM, from 67 to 260.
- Jan 2, 2026
Monthly visitors grew 696% MoM.
ExCulture Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ExCulture's valuation, stock price, and market status.
Is ExCulture a public or private company?
ExCulture is a private company.
What is the current stock price of ExCulture?
ExCulture is a private company with no public stock price. No recent secondary market data is available.
How much is ExCulture worth (valuation)?
Valuation information for ExCulture is not publicly available.
Can I buy ExCulture stock?
ExCulture shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ExCulture's last funding round?
ExCulture's most recent funding round was Seed on July 12, 2024.
Who are the main investors in ExCulture?
Key investors in ExCulture include Capricorn Partners, Libertatis Ergo Holding, Netherlands Organization for Scientific Research, Life Sciences @ Work Venture Challenge, Innovation Industries.
Will ExCulture IPO soon?
No public IPO plans have been announced for ExCulture.
How can I track ExCulture secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExCulture's secondary market activity and sign up for updates.